Indeed Snapshot

Track Agios Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 29th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 29th, 2022 11:18AM Aug 29th, 2022 11:18AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 28th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 28th, 2022 04:18AM Aug 28th, 2022 04:18AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 27th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 27th, 2022 03:38AM Aug 27th, 2022 03:38AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 25th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 25th, 2022 08:17AM Aug 25th, 2022 08:17AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 23rd, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 23rd, 2022 10:10AM Aug 23rd, 2022 10:10AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 21st, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 21st, 2022 11:54AM Aug 21st, 2022 11:54AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 20th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 20th, 2022 01:31PM Aug 20th, 2022 01:31PM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 19th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 19th, 2022 11:54AM Aug 19th, 2022 11:54AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 18th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 18th, 2022 03:38AM Aug 18th, 2022 03:38AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio https://www.indeed.com/cmp/agios-pharmaceuticals Aug 17th, 2022 12:00AM Open Agios Pharmaceuticals Pharmaceutical Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. RRv1_25M_100M Cambridge, MA 4.30 15.00 15.00 4.20 4.50 3.90 3.90 3.90 6.00 About a week 8.00 MEDIUM 8.00 FAVORABLE Aug 17th, 2022 09:17AM Aug 17th, 2022 09:17AM Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.